Chaperones and Proteostasis: Role in Parkinson’s Disease

Gitler, 2017, Neurodegenerative disease: Models, mechanisms, and a new hope, Dis. Model. Mech., 10, 499, 10.1242/dmm.030205

Bandopadhyay, 2010, Pathogenesis of Parkinson’s disease: Emerging role of molecular chaperones, Trends. Mol. Med., 16, 27, 10.1016/j.molmed.2009.11.004

Dimant, 2012, Molecular chaperones and co-chaperones in Parkinson disease, Neuroscientist, 18, 589, 10.1177/1073858412441372

Klein, 2012, Genetics of Parkinson’s disease, Cold Spring Harb. Perspect. Med., 2, a008888, 10.1101/cshperspect.a008888

Miller, 2010, Gender differences in Parkinson’s disease: Clinical characteristics and cognition, Mov. Disord., 25, 2695, 10.1002/mds.23388

Maiti, 2017, Current understanding of the molecular mechanisms in Parkinson’s disease: Targets for potential treatments, Transl. Neurodegener., 6, 28, 10.1186/s40035-017-0099-z

Stoker, T., and Greenland, J. (2018). Pathological Mechanisms and Clinical Aspects of GBA1 Mutation-Associated Parkinson’s Disease. Parkinson’s Disease: Pathogenesis and Clinical Aspects, Codon Publications.

Poewe, 2017, Parkinson disease, Nat. Rev. Dis. Primers, 3, 1, 10.1038/nrdp.2017.13

Sironi, L., Restelli, L.M., Tolnay, M., Neutzner, A., and Frank, S. (2020). Dysregulated interorganellar crosstalk of mitochondria in the pathogenesis of Parkinson’s disease. Cells, 9.

Hartl, 2002, Molecular chaperones in the cytosol: From nascent chain to folded protein, Science, 295, 1852, 10.1126/science.1068408

Kim, 2013, Molecular chaperone functions in protein folding and proteostasis, Annu. Rev. Biochem., 82, 323, 10.1146/annurev-biochem-060208-092442

Pickart, 2004, Proteasomes and their kin: Proteases in the machine age, Nat. Rev. Mol. Cell Biol., 5, 177, 10.1038/nrm1336

Alexopoulos, 2012, ClpP: A structurally dynamic protease regulated by AAA+ proteins, J. Struct. Biol., 179, 202, 10.1016/j.jsb.2012.05.003

Li, 2013, Examination of the polypeptide substrate specificity for Escherichia coli ClpA, Biochemistry, 52, 4941, 10.1021/bi400178q

Morimoto, 2008, Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging, Gene. Dev., 22, 1427, 10.1101/gad.1657108

Stefanis, 2012, α-Synuclein in Parkinson’s disease, Cold Spring Harb. Perspect. Med., 2, a009399, 10.1101/cshperspect.a009399

Wakabayashi, 2007, The Lewy body in Parkinson’s disease: Molecules implicated in the formation and degradation of α-synuclein aggregates, Neuropathology, 27, 494, 10.1111/j.1440-1789.2007.00803.x

Bartels, 2011, α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation, Nature, 477, 107, 10.1038/nature10324

Vivona, 2013, Properties of native brain α-synuclein, Nature, 498, E4, 10.1038/nature12125

Outeiro, 2015, The interplay between alpha-synuclein clearance and spreading, Biomolecules, 5, 435, 10.3390/biom5020435

Bohush, A., Bieganowski, P., and Filipek, A. (2019). Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases. Int. J. Mol. Sci., 20.

Polymeropoulos, 1997, Mutation in the α-synuclein gene identified in families with Parkinson’s disease, Science, 276, 2045, 10.1126/science.276.5321.2045

Kuhn, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease, Nat. Genet., 18, 106, 10.1038/ng0298-106

Zarranz, 2004, The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia, Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc., 55, 164

Li, 2019, The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases, Front. Neurosci., 13, 381, 10.3389/fnins.2019.00381

Meade, 2019, Alpha-synuclein structure and Parkinson’s disease–lessons and emerging principles, Mol. Neurodegener., 14, 29, 10.1186/s13024-019-0329-1

Narkiewicz, 2014, In vitro aggregation assays for the characterization of α-synuclein prion-like properties, Prion, 8, 19, 10.4161/pri.28125

Hoter, A., El-Sabban, M.E., and Naim, H.Y. (2018). The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease. Int. J. Mol. Sci., 19.

Falsone, 2009, The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein α-synuclein, J. Biol. Chem., 284, 31190, 10.1074/jbc.M109.057240

Uryu, 2006, Convergence of heat shock protein 90 with ubiquitin in filamentous α-synuclein inclusions of α-synucleinopathies, Am. J. Clin. Pathol., 168, 947, 10.2353/ajpath.2006.050770

Liang, 2008, Novel suppressors of α-synuclein toxicity identified using yeast, Hum. Mol. Genet., 17, 3784, 10.1093/hmg/ddn276

Putcha, 2010, Brain-permeable small-molecule inhibitors of Hsp90 prevent α-synuclein oligomer formation and rescue α-synuclein-induced toxicity, J. Pharmacol. Exp. Ther., 332, 849, 10.1124/jpet.109.158436

Butler, E.K., Voigt, A., Lutz, A.K., Toegel, J.P., Gerhardt, E., Karsten, P., Falkenburger, B., Reinartz, A., Winklhofer, K.F., and Schulz, J.B. (2012). The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. PLoS Genet., 8.

Rane, 2018, Hsp90 Co-chaperone p23 contributes to dopaminergic mitochondrial stress via stabilization of PHD2: Implications for Parkinson’s disease, Neurotoxicology, 65, 166, 10.1016/j.neuro.2018.02.012

Cox, 2014, Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins, Biochim. Biophys. Acta, 1842, 1830, 10.1016/j.bbadis.2014.06.024

Waudby, 2010, The interaction of αB-crystallin with mature α-synuclein amyloid fibrils inhibits their elongation, Biophys. J., 98, 843, 10.1016/j.bpj.2009.10.056

Cox, 2018, The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity, J. Biol. Chem., 293, 4486, 10.1074/jbc.M117.813865

Bruinsma, 2011, Inhibition of α-synuclein aggregation by small heat shock proteins, Proteins, 79, 2956, 10.1002/prot.23152

Sharma, 2017, Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s disease, Cell. Mol. Life Sci., 74, 617, 10.1007/s00018-016-2340-9

Gao, 2015, Human Hsp70 disaggregase reverses Parkinson’s-linked α-synuclein amyloid fibrils, Mol. Cell, 59, 781, 10.1016/j.molcel.2015.07.012

Bianco, 2008, Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease, J. Clin. Investig., 118, 3087, 10.1172/JCI35781

McLean, 2002, TorsinA and heat shock proteins act as molecular chaperones: Suppression of α-synuclein aggregation, J. Neurochem., 83, 846, 10.1046/j.1471-4159.2002.01190.x

Jarvela, 2016, The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity, Proc. Natl. Acad. Sci. USA, 113, E4708, 10.1073/pnas.1601091113

Han, 2009, Rescue of Munc18-1 and-2 double knockdown reveals the essential functions of interaction between Munc18 and closed syntaxin in PC12 cells, Mol. Biol. Cell, 20, 4962, 10.1091/mbc.e09-08-0712

Chai, 2016, Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation, J. Cell Biol., 214, 705, 10.1083/jcb.201512016

Mishina, 2005, Function of sigma1 receptors in Parkinson’s disease, Acta Neurol. Scand., 112, 103, 10.1111/j.1600-0404.2005.00432.x

Hong, 2017, Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra, Neurobiol. Aging, 59, 171, 10.1016/j.neurobiolaging.2017.08.007

Bisaglia, M., and Bubacco, L. (2020). Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?. Biomolecules, 10.

Carboni, 2015, Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson’s disease, Metallomics, 7, 395, 10.1039/C4MT00339J

Horvath, 2019, Interaction between Copper Chaperone Atox1 and Parkinson’s Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells, ACS Chem. Neurosci., 10, 4659, 10.1021/acschemneuro.9b00476

Horvath, 2018, Copper chaperone blocks amyloid formation via ternary complex, Q. Rev. Biophys., 51, e6, 10.1017/S0033583518000045

Okita, 2017, Metallothionein, copper and alpha-synuclein in alpha-synucleinopathies, Front. Neurosci., 11, 114, 10.3389/fnins.2017.00114

Lee, 2019, Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone, Brain, 142, 2845, 10.1093/brain/awz205

Daugaard, 2007, The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions, FEBS Lett., 581, 3702, 10.1016/j.febslet.2007.05.039

Kelley, 1998, The J-domain family and the recruitment of chaperone power, Trends Biochem. Sci., 23, 222, 10.1016/S0968-0004(98)01215-8

Sharma, 2010, The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase, Nat. Chem. Biol., 6, 914, 10.1038/nchembio.455

Minami, 1995, Hip, a novel cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle, Cell, 83, 589, 10.1016/0092-8674(95)90099-3

Nollen, 2000, Bag1 functions in vivo as a negative regulator of Hsp70 chaperone activity, Mol. Cellular Biol., 20, 1083, 10.1128/MCB.20.3.1083-1088.2000

Scherzer, 2007, Molecular markers of early Parkinson’s disease based on gene expression in blood, Proc. Natl. Acad. Sci. USA, 104, 955, 10.1073/pnas.0610204104

Klucken, 2004, Hsp70 reduces α-synuclein aggregation and toxicity, J. Biol. Chem., 279, 25497, 10.1074/jbc.M400255200

Auluck, 2002, Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson’s disease, Science, 295, 865, 10.1126/science.1067389

Pemberton, 2011, Hsc70 protein interaction with soluble and fibrillar α-synuclein, J. Biol. Chem., 286, 34690, 10.1074/jbc.M111.261321

Priya, 2013, GroEL and CCT are catalytic unfoldases mediating out-of-cage polypeptide refolding without ATP, Proc. Natl. Acad. Sci. USA, 110, 7199, 10.1073/pnas.1219867110

Yamamoto, H., Fukui, N., Adachi, M., Saiki, E., Yamasaki, A., Matsumura, R., Kuroyanagi, D., Hongo, K., Mizobata, T., and Kawata, Y. (2020). Human Molecular Chaperone Hsp60 and Its Apical Domain Suppress Amyloid Fibril Formation of α-Synuclein. Int. J. Mol. Sci., 21.

Sluchanko, 2017, Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins, FEBS J., 284, 1279, 10.1111/febs.13986

Wang, 2018, 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein, J. Neurosci., 38, 8211, 10.1523/JNEUROSCI.1134-18.2018

Martinat, C., Shendelman, S., Jonason, A., Leete, T., Beal, M.F., Yang, L., Floss, T., and Abeliovich, A. (2004). Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: An ES-derived cell model of primary Parkinsonism. PLoS Biol., 2.

Zondler, 2014, DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson’s disease, Cell Death Dis., 5, e1350, 10.1038/cddis.2014.307

Cuervo, 2004, Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy, Science, 305, 1292, 10.1126/science.1101738

Webb, 2003, α-Synuclein is degraded by both autophagy and the proteasome, J. Biol. Chem., 278, 25009, 10.1074/jbc.M300227200

Ciechanover, 2017, Protein quality control by molecular chaperones in neurodegeneration, Front. Neurosci., 11, 185, 10.3389/fnins.2017.00185

Wahlster, 2011, Molecular chaperones in Parkinson’s disease–present and future, J. Parkinsons Dis., 1, 299, 10.3233/JPD-2011-11044

Tsai, 2003, Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function, J. Biol. Chem., 278, 22044, 10.1074/jbc.M212235200

Friesen, 2017, Chaperone-based therapies for disease modification in Parkinson’s disease, Parkinson’s Dis., 22017, 5015307

Connell, 2001, The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins, Nat. Cell Biol., 3, 93, 10.1038/35050618

Kalia, L.V., Kalia, S.K., Chau, H., Lozano, A.M., Hyman, B.T., and McLean, P.J. (2011). Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS ONE, 6.

Shin, 2005, The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal pathways, J. Biol. Chem., 280, 23727, 10.1074/jbc.M503326200

Jiang, 2001, CHIP is a U-box-dependent E3 ubiquitin ligase identification of Hsc70 as a target for ubiquitylation, J. Biol. Chem., 276, 42938, 10.1074/jbc.M101968200

Tetzlaff, 2008, CHIP targets toxic α-synuclein oligomers for degradation, J. Biol. Chem., 283, 17962, 10.1074/jbc.M802283200

Takayama, 1997, BAG-1 modulates the chaperone activity of Hsp70/Hsc70, EMBO J., 16, 4887, 10.1093/emboj/16.16.4887

Demand, 2000, The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome, J. Biol. Chem., 275, 4613, 10.1074/jbc.275.7.4613

Demand, 2001, Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling, Curr. Biol., 11, 1569, 10.1016/S0960-9822(01)00487-0

Deshayes, N., Arkan, S., and Hansen, C. (2019). The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells. Int. J. Mol. Sci., 20.

Engelender, 2008, Ubiquitination of α-synuclein and autophagy in Parkinson’s disease, Autophagy, 4, 372, 10.4161/auto.5604

Rott, 2008, Monoubiquitylation of α-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells, J. Biol. Chem., 283, 3316, 10.1074/jbc.M704809200

Rott, 2011, α-Synuclein fate is determined by USP9X-regulated monoubiquitination, Proc. Natl. Acad. Sci. USA, 108, 18666, 10.1073/pnas.1105725108

Machiya, 2010, Phosphorylated α-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner, J. Biol. Chem., 285, 40732, 10.1074/jbc.M110.141952

Bentea, 2017, The proteasome inhibition model of Parkinson’s disease, J. Parkinsons Dis., 7, 31, 10.3233/JPD-160921

Stefanis, 2001, Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death, J. Neurosci., 21, 9549, 10.1523/JNEUROSCI.21-24-09549.2001

Emmanouilidou, 2010, Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome, Neurobiol. Aging, 31, 953, 10.1016/j.neurobiolaging.2008.07.008

Chu, 2009, Alterations in lysosomal and proteasomal markers in Parkinson’s disease: Relationship to alpha-synuclein inclusions, Neurobiol. Dis., 35, 385, 10.1016/j.nbd.2009.05.023

Zondler, L., Kostka, M., Garidel, P., Heinzelmann, U., Hengerer, B., Mayer, B., Weishaupt, J.H., Gillardon, F., and Danzer, K.M. (2017). Proteasome impairment by α-synuclein. PLoS ONE, 12.

Ghee, 2000, Rat α-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex, J. Neurochem., 75, 2221, 10.1046/j.1471-4159.2000.0752221.x

Tripathi, 2019, Malfunctioning of chaperone-mediated autophagy in Parkinson’s disease: Feats, constraints, and flaws of modulators, Neurotox. Res., 35, 260, 10.1007/s12640-018-9917-z

Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., and Stefanis, L. (2009). Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE, 4.

Mak, 2010, Lysosomal degradation of α-synuclein in vivo, J. Biol. Chem., 285, 13621, 10.1074/jbc.M109.074617

Talloczy, 2008, Dopamine-modified α-synuclein blocks chaperone-mediated autophagy, J. Clin. Investig., 118, 777

Vogiatzi, 2008, Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells, J. Biol. Chem., 283, 23542, 10.1074/jbc.M801992200

Cooper, 2010, Chaperone-mediated autophagy markers in Parkinson disease brains, Arch. Neurol., 67, 1464

Seow, 2013, Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson’s disease, Cell Death Dis., 4, e545, 10.1038/cddis.2013.73

Li, 2014, Targeted suppression of chaperone-mediated autophagy by miR-320a promotes α-synuclein aggregation, Int. J. Mol. Sci., 15, 15845, 10.3390/ijms150915845

Xilouri, 2016, Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats, Autophagy, 12, 2230, 10.1080/15548627.2016.1214777

Sun, 2019, The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure, Brain Behav., 9, e01352, 10.1002/brb3.1352

Xu, 2017, DJ-1 inhibits α-synuclein aggregation by regulating chaperone-mediated autophagy, Front. Aging Neurosci., 9, 308, 10.3389/fnagi.2017.00308

Noda, 2002, Yeast autophagosomes: De novo formation of a membrane structure, Trends Cell Biol., 12, 231, 10.1016/S0962-8924(02)02278-X

Kraft, 2012, Mechanisms and regulation of autophagosome formation, Curr. Opin. Cell Biol., 24, 496, 10.1016/j.ceb.2012.05.001

Reggiori, 2004, The Atg1-Atg13 complex regulates Atg9 and Atg23 retrieval transport from the pre-autophagosomal structure, Dev. Cell, 6, 79, 10.1016/S1534-5807(03)00402-7

Young, 2006, Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes, J. Cell Sci., 119, 3888, 10.1242/jcs.03172

Romanov, 2012, Mechanism and functions of membrane binding by the Atg5–Atg12/Atg16 complex during autophagosome formation, EMBO J., 31, 4304, 10.1038/emboj.2012.278

Tanida, 2004, HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3-and GABAA receptor-associated protein-phospholipid conjugates, J. Biol. Chem., 279, 36268, 10.1074/jbc.M401461200

Huang, 2012, Macroautophagy in sporadic and the genetic form of Parkinson’s disease with the A53T α-synuclein mutation, Transl. Neurodegener., 1, 2, 10.1186/2047-9158-1-2

Olzmann, 2007, Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6, J. Cell Biol., 178, 1025, 10.1083/jcb.200611128

Kirkin, 2009, A role for NBR1 in autophagosomal degradation of ubiquitinated substrates, Mol. Cell, 33, 505, 10.1016/j.molcel.2009.01.020

Tan, 2008, Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases, Hum. Mol. Gen., 17, 431, 10.1093/hmg/ddm320

Miki, 2011, Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions, Neuropathology, 31, 561, 10.1111/j.1440-1789.2011.01200.x

Du, 2014, Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response, Neurobiol. Aging, 35, 2316, 10.1016/j.neurobiolaging.2014.04.029

Zhang, 2011, Chaperone-mediated hierarchical control in targeting misfolded proteins to aggresomes, Mol. Biol. Cell, 22, 3277, 10.1091/mbc.e11-05-0388

Cao, 2017, A role of BAG3 in regulating SNCA/α-synuclein clearance via selective macroautophagy, Neurobiol. Aging, 60, 104, 10.1016/j.neurobiolaging.2017.08.023

McGlinchey, 2015, Cysteine cathepsins are essential in lysosomal degradation of α-synuclein, Proc. Natl. Acad. Sci. USA, 112, 9322, 10.1073/pnas.1500937112

Vidoni, 2016, The role of cathepsin D in the pathogenesis of human neurodegenerative disorders, Med. Res. Rev., 36, 845, 10.1002/med.21394

Cullen, 2011, Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing, Ann. Neurol., 69, 940, 10.1002/ana.22400

Abdelmotilib, 2017, α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic neurodegeneration, Neurobiol. Dis., 105, 84, 10.1016/j.nbd.2017.05.014

Lee, 2014, Extracellular α-synuclein—A novel and crucial factor in Lewy body diseases, Nat. Rev. Neurol., 10, 92, 10.1038/nrneurol.2013.275

Danzer, 2011, Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity, FASEB J., 25, 326, 10.1096/fj.10-164624

Dehay, 2016, Alpha-synuclein propagation: New insights from animal models, Mov. Disord., 31, 161, 10.1002/mds.26370

Fontaine, 2016, DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins, EMBO J., 35, 1537, 10.15252/embj.201593489

Liu, 2009, Rab11a and HSP90 regulate recycling of extracellular α-synuclein, J. Neurosci., 29, 1480, 10.1523/JNEUROSCI.6202-08.2009

Rey, 2016, Spreading the word: Precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein, Neuropathol. Appl. Neurobiol., 42, 51, 10.1111/nan.12299

Tyson, 2016, Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology, J. Neurochem., 139, 275, 10.1111/jnc.13449

Taylor, 2018, Cryo-EM structure of alpha-synuclein fibrils, Elife, 7, e36402, 10.7554/eLife.36402

Surguchev, A.A., Emamzadeh, F.N., and Surguchov, A. (2019). Cell responses to extracellular α-synuclein. Molecules, 24.

Dias, 2012, Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation, J. Neurosci., 32, 11750, 10.1523/JNEUROSCI.0234-12.2012

Shrivastava, 2015, α-synuclein assemblies sequester neuronal α3-Na+/K+-ATPase and impair Na+ gradient, EMBO J., 34, 2408, 10.15252/embj.201591397

Whiten, 2018, Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers, Cell Rep., 23, 3492, 10.1016/j.celrep.2018.05.074

Blauwendraat, 2020, The genetic architecture of Parkinson’s disease, Lancet Neurol., 19, 170, 10.1016/S1474-4422(19)30287-X

Trempe, 2013, Structure and function of Parkin, PINK1, and DJ-1, the three musketeers of neuroprotection, Front. Neurol., 4, 38, 10.3389/fneur.2013.00038

Wahabi, 2018, Parkin in Parkinson’s disease and Cancer: A double-edged sword, Mol. Neurobiol., 55, 6788, 10.1007/s12035-018-0879-1

Sarraf, 2013, Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization, Nature, 496, 372, 10.1038/nature12043

Schlossmacher, 2002, Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies, Am. J. Clin. Pathol., 160, 1655, 10.1016/S0002-9440(10)61113-3

Dawson, 2010, The role of parkin in familial and sporadic Parkinson’s disease, Mov. Disord., 25, S32, 10.1002/mds.22798

Imai, 2002, CHIP is associated with Parkin, a gene responsible for familial Parkinson’s disease, and enhances its ubiquitin ligase activity, Mol. Cell, 10, 55, 10.1016/S1097-2765(02)00583-X

Winklhofer, 2003, Inactivation of Parkin by oxidative stress and C-terminal truncations a protective role of molecular chaperones, J. Biol. Chem., 278, 47199, 10.1074/jbc.M306769200

Kalia, 2004, BAG5 inhibits parkin and enhances dopaminergic neuron degeneration, Neuron, 44, 931, 10.1016/j.neuron.2004.11.026

Geisler, 2010, PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1, Nat. Cell Biol., 12, 119, 10.1038/ncb2012

Yang, 2011, Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin, Biochem. Biophys. Res. Commun., 410, 114, 10.1016/j.bbrc.2011.05.116

Rose, 2011, Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1 domain mutant, Hum. Mol. Gen., 20, 16, 10.1093/hmg/ddq428

Kakkar, 2016, Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G, Sci. Rep., 6, 1, 10.1038/srep34830

Davison, 2009, Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function, Proteomics, 9, 4284, 10.1002/pmic.200900126

Rakovic, A., Grünewald, A., Voges, L., Hofmann, S., Orolicki, S., Lohmann, K., and Klein, C. (2011). PINK1-interacting proteins: Proteomic analysis of overexpressed PINK1. Parkinsons Dis., 2011.

Costa, 2013, Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson’s disease, Cell Death Dis., 4, e467, 10.1038/cddis.2012.205

Sato, 2006, 14-3-3eta is a novel regulator of parkin ubiquitin-ligase, Mov. Disord., 25, 211

Valente, 2004, Hereditary early-onset Parkinson’s disease caused by mutations in PINK1, Science, 304, 1158, 10.1126/science.1096284

Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A.S., Miljan, E.A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., and Deas, E. (2008). PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE, 3.

Weihofen, 2008, Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1, Hum. Mol. Gen., 17, 602, 10.1093/hmg/ddm334

Moriwaki, 2008, L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner, Neurosci. Res., 61, 43, 10.1016/j.neures.2008.01.006

Lin, 2008, Characterization of PINK1 processing, stability, and subcellular localization, J. Neurochem., 106, 464, 10.1111/j.1471-4159.2008.05398.x

Qu, 2015, BAG2 gene-mediated regulation of PINK1 protein is critical for mitochondrial translocation of PARKIN and neuronal survival, J. Biol. Chem., 290, 30441, 10.1074/jbc.M115.677815

Zhang, 2013, TRAP1 rescues PINK1 loss-of-function phenotypes, Hum. Mol. Gen., 22, 2829, 10.1093/hmg/ddt132

Kim, 2012, Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling, J. Biol. Chem., 287, 44109, 10.1074/jbc.M112.408146

Honbou, 2003, The crystal structure of DJ-1, a protein related to male fertility and Parkinson’s disease, J. Biol. Chem., 278, 31380, 10.1074/jbc.M305878200

Malgieri, 2008, Structural effects of Parkinson’s disease linked DJ-1 mutations, Protein Sci., 17, 855, 10.1110/ps.073411608

Ariga, 2013, Neuroprotective function of DJ-1 in Parkinson’s disease, Oxid. Med. Cell. Longev., 2013, 683920, 10.1155/2013/683920

Nagakubo, 1997, DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation withras, Biochem. Biophys. Res. Commun., 231, 509, 10.1006/bbrc.1997.6132

Saito, 2014, Immunostaining of oxidized DJ-1 in human and mouse brains, J. Neuropathol. Exp. Neurol., 73, 714, 10.1097/NEN.0000000000000087

Bandopadhyay, 2004, The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson’s disease, Brain, 127, 420, 10.1093/brain/awh054

Li, 2005, Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress, Free Radic. Res., 39, 1091, 10.1080/10715760500260348

Maita, C., Maita, H., Iguchi-Ariga, S.M., and Ariga, H. (2013). Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants. PLoS ONE, 8.

Qin, 2017, BAG5 Interacts with DJ-1 and inhibits the neuroprotective effects of DJ-1 to combat mitochondrial oxidative damage, Oxid. Med. Cell. Longev., 2017, 5094934, 10.1155/2017/5094934

Deeg, 2010, BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity, J. Cell Biol., 188, 505, 10.1083/jcb.200904103

Moore, 2005, Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress, Hum. Mol. Gen., 14, 71, 10.1093/hmg/ddi007

Bosgraaf, 2003, Roc, a Ras/GTPase domain in complex proteins, Mol. Cell. Res., 1643, 5

Tsika, 2013, Contribution of GTPase activity to LRRK2-associated Parkinson disease, Small GTPases, 4, 164, 10.4161/sgtp.25130

Rui, 2018, The role of LRRK2 in neurodegeneration of parkinson disease, Curr. Neuropharmacol., 16, 1348, 10.2174/1570159X16666180222165418

Tolosa, 2020, LRRK2 in Parkinson disease: Challenges of clinical trials, Nat. Rev. Neurol., 16, 97, 10.1038/s41582-019-0301-2

Berwick, 2019, LRRK2 Biology from structure to dysfunction: Research progresses, but the themes remain the same, Mol. Neurodegener., 14, 1, 10.1186/s13024-019-0344-2

Healy, 2008, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: A case-control study, Lancet Neurol., 7, 583, 10.1016/S1474-4422(08)70117-0

Wang, 2008, The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2, J. Neurosci., 28, 3384, 10.1523/JNEUROSCI.0185-08.2008

Ko, 2009, CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity, Proc. Natl. Acad. Sci. USA, 106, 2897, 10.1073/pnas.0810123106

Ding, X., and Goldberg, M.S. (2009). Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS ONE, 4.

Fukuzono, 2016, Chaperone complex BAG 2–HSC 70 regulates localization of Caenorhabditis elegans leucine-rich repeat kinase LRK-1 to the Golgi, Genes Cells, 21, 311, 10.1111/gtc.12338

Orenstein, 2013, Interplay of LRRK2 with chaperone-mediated autophagy, Nat. Neurosci., 16, 394, 10.1038/nn.3350

Sala, 2016, Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease, Front. Mol. Neurosci., 9, 157, 10.3389/fnmol.2016.00157

Nichols, 2010, 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson’s disease-associated mutations and regulates cytoplasmic localization, Biochem. J., 430, 393, 10.1042/BJ20100483

Kampinga, 2010, The HSP70 chaperone machinery: J proteins as drivers of functional specificity, Nat. Rev. Mol. Cell Biol., 11, 579, 10.1038/nrm2941

Hasegawa, 2018, DnaJ/Hsp40 family and Parkinson’s disease, Front. Neurosci., 11, 743, 10.3389/fnins.2017.00743

Zarouchlioti, 2018, DNAJ Proteins in neurodegeneration: Essential and protective factors, Philos. Trans. R. Soc. Lond. B Biol. Sci., 373, 20160534, 10.1098/rstb.2016.0534

Olgiati, 2016, DNAJC6 Mutations Associated with Early-Onset Parkinson’s Disease, Ann. Neurol., 79, 244, 10.1002/ana.24553

Ungewickell, 1995, Role of auxilin in uncoating clathrin-coated vesicles, Nature, 378, 632, 10.1038/378632a0

Morgan, 2001, Uncoating of clathrin-coated vesicles in presynaptic terminals: Roles for Hsc70 and auxilin, Neuron, 32, 289, 10.1016/S0896-6273(01)00467-6

Roosen, 2019, DNAJC proteins and pathways to parkinsonism, FEBS J., 286, 3080, 10.1111/febs.14936

Nguyen, 2018, LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson’s disease, Proc. Natl. Acad. Sci. USA, 115, 5576, 10.1073/pnas.1717590115

Jones, 2014, Targeting heat shock proteins to modulate α-synuclein toxicity, Ther. Adv. Neurol. Disord., 7, 33, 10.1177/1756285613493469

Varkey, 2010, Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins, J. Biol. Chem., 285, 32486, 10.1074/jbc.M110.139576

Wang, 2011, A soluble α-synuclein construct forms a dynamic tetramer, Proc. Natl. Acad. Sci. USA, 108, 17797, 10.1073/pnas.1113260108

Liu, 2015, Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains, Neurobiol. Aging, 36, 2649, 10.1016/j.neurobiolaging.2015.06.004

Paleologou, 2010, Phosphorylation at S87 is enhanced in synucleinopathies, inhibits α-synuclein oligomerization, and influences synuclein-membrane interactions, J. Neurosci., 30, 3184, 10.1523/JNEUROSCI.5922-09.2010

Oueslati, 2016, Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?, J. Parkinsons Dis., 6, 39, 10.3233/JPD-160779

Meier, 2012, Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation, J. Am. Chem. Soc., 134, 5468, 10.1021/ja300094r

Rott, 2017, SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation, Proc. Natl. Acad. Sci. USA, 114, 13176, 10.1073/pnas.1704351114

Giasson, 2000, Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions, Science, 290, 985, 10.1126/science.290.5493.985

Liu, 2011, A novel molecular mechanism for nitrated α-synuclein-induced cell death, J. Mol. Cell Biol., 3, 239, 10.1093/jmcb/mjr011

Danielson, 2009, Preferentially increased nitration of α-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson’s disease, Anal. Chem., 81, 7823, 10.1021/ac901176t

Lewis, 2017, O-GlcNAcylation of α-synuclein at serine 87 reduces aggregation without affecting membrane binding, ACS Chem. Biol., 12, 1020, 10.1021/acschembio.7b00113

Levine, 2019, α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson’s disease, Proc. Natl. Acad. Sci. USA, 116, 1511, 10.1073/pnas.1808845116

Duce, 2017, Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease, Mol. Neurodegener., 12, 45, 10.1186/s13024-017-0186-8

Cookson, 2010, The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease, Nat. Rev. Neurosci., 11, 791, 10.1038/nrn2935

Pickrell, 2015, The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease, Neuron, 85, 257, 10.1016/j.neuron.2014.12.007

Kalia, 2016, Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD, Nat. Rev. Neurol., 12, 65, 10.1038/nrneurol.2015.249